G Medical Innovations IPO Presentation Deck
Financial Summary
Summary Operations Data
U.S. dollars in thousands
Total Revenue
Total Cost of Revenue
Gross Profit (loss)
Operating Income (loss)
Net Comprehensive Income
(loss)
For the year ended December 31
2021
2020
$5,058
$3,556
$1,502
$(11,269)
$(14,888)
$4,900
$4,233
$667
$(12,300)
$(12,688)
For the six months ended June 30
2022
2021
$2,224
$7,141
$(4,917)
1
2
$(20,789)
$(13,287)
$2,925
$1,784
$1,141
$(4,273)
$(4,771)
1. The increase in cost of revenues was mainly related to the increase in our COVID-19 services activity, partially offset by a 6% decrease in the cost of revenues from patient services. The costs
related to our COVID-19 service activity includes approximately $2.8 million which are associated with revenues not yet recognized that will be recognized on cash basis.
2. Includes $3.3 million in share-based compensation and $3 million in professional services expenses.
20View entire presentation